These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 696422)

  • 1. Serum aminotransferases after low-dose heparin treatment. Short communication.
    Olsson R; Korsan-Bengtsen BM; Korsan-Bengtsen K; Lennartsson J; Waldenström J
    Acta Med Scand; 1978; 204(3):229-30. PubMed ID: 696422
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic and prognostic value of serum transaminases].
    CAMPANA C
    Policlinico Prat; 1960 Nov; 67():1617-32. PubMed ID: 14448585
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of the determination of serum glutamic-oxalacetic transaminase and serum glutamic-pyruvic transaminase in the diagnosis of myocardial infarct and liver disease].
    BOSTANCI N; BIYAL F
    Turk Tip Cemiy Mecm; 1959 Sep; 25():444-54. PubMed ID: 13803091
    [No Abstract]   [Full Text] [Related]  

  • 4. Marked but transitory elevation of hepatic transaminases after subcutaneous calcium heparin administration.
    Tison T; Dazzi F; Vianello F; Radossi P; Girolami A
    Acta Haematol; 1994; 92(1):54. PubMed ID: 7985487
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and laboratory correlation of the transaminase test, an analysis of 111 patients for a period of thirteen months.
    HAND AM; WILSON JW
    J La State Med Soc; 1960 May; 112():161-6. PubMed ID: 14399437
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical examination of heparin-Ca in myocardial infarction patients.
    Páder K; Kerkovits G
    Ther Hung; 1990; 38(3):114-6. PubMed ID: 2284620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose heparin after myocardial infarction.
    Handley AJ
    Lancet; 1972 Sep; 2(7778):623-4. PubMed ID: 4116776
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcutaneous enoxaparin following thrombolysis and intravenous unfractionated heparin in ST-elevation acute myocardial infarction: safety and efficacy of low vs full dose.
    Rubboli A; Gatti C; Spinolo L; Parollo R; Spitali G; Maresta A
    Minerva Cardioangiol; 2006 Feb; 54(1):131-7. PubMed ID: 16467747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous heparin. A logical prophylaxis for deep vein thrombosis after myocardial infarction.
    Marks P; Teather D
    Practitioner; 1978 Mar; 220(1317):425-7. PubMed ID: 643788
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-dose subcutaneous heparin in prevention of deep-vein thrombosis.
    Drug Ther Bull; 1972 Nov; 10(23):89-91. PubMed ID: 4656672
    [No Abstract]   [Full Text] [Related]  

  • 11. [The differential diagnosis between myocardial- and lung infarction by the determination of serum enzyme activity].
    KLAUS D; ZEH E
    Dtsch Med Wochenschr; 1961 Mar; 86():480-3. PubMed ID: 13756572
    [No Abstract]   [Full Text] [Related]  

  • 12. [1000 transaminases readings].
    Hagemann P
    Schweiz Rundsch Med Prax; 1981 May; 70(19):844-8. PubMed ID: 7243724
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma free-fatty-acids and small doses of subcutaneous heparin in acute myocardial infarction.
    Arnesen H; Bjerkedal I; Skjaeggestad O; Godal HC
    Thromb Res; 1979; 14(4-5):541-9. PubMed ID: 483254
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction.
    Warlow C; Terry G; Kenmure AC; Beattie AG; Ogston D; Douglas AS
    Lancet; 1973 Oct; 2(7835):934-6. PubMed ID: 4126560
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.
    Turpie AG; Robinson JG; Doyle DJ; Mulji AS; Mishkel GJ; Sealey BJ; Cairns JA; Skingley L; Hirsh J; Gent M
    N Engl J Med; 1989 Feb; 320(6):352-7. PubMed ID: 2643772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of serum transaminase levels in the differentiation of pulmonary embolism and myocardial infarction.
    GOLDSTEIN F; ISRAEL HL; SELIGSON D
    N Engl J Med; 1956 Apr; 254(16):746-9. PubMed ID: 13309669
    [No Abstract]   [Full Text] [Related]  

  • 17. Conjunctive heparin therapy. Limitations of subcutaneous administration.
    Goldhaber SZ
    Circulation; 1992 Nov; 86(5):1639-41. PubMed ID: 1423976
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous heparin during coronary thrombolysis. Too little, too late.
    Delanty N; Fitzgerald DJ
    Circulation; 1992 Nov; 86(5):1636-8. PubMed ID: 1423975
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up of heparin to prevent myocardial infarction.
    Neri Serneri GG; Gensini GF; Comeglio M
    Lancet; 1993 Jul; 342(8862):48. PubMed ID: 8100312
    [No Abstract]   [Full Text] [Related]  

  • 20. SGOT and LDH in myocardial infarction; their comparative value.
    UMIKER WO; BOITER T
    Pa Med J; 1962 Mar; 65():342-6. PubMed ID: 13923773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.